Physician profile
Harold E Cook
NPI 1982052031
$3,000.95
in general payments reported to CMS, 2019-2025
16 companies · $731 in 2025
The $731 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.00 · 2020: $94.77 · 2021: $31.35 · 2022: $1,371 · 2023: $536 · 2024: $203 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,335 · Travel and Lodging: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,335.29 |
| Travel and Lodging | $134.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $1,288.53 | 2022 | |
| Treace Medical Concepts, INC. | $452.17 | 2025 | |
| Organogenesis INC. | $437.75 | 2023-2025 | Novachor, Affinity, Puraply |
| Stryker Corporation | $232.15 | 2020-2025 | Citrefix, Prostep Mica, Ortholoc 3di |
| Progenacare Global, LLC | $186.44 | 2023 | |
| Smith+Nephew, INC. | $94.81 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Grafix Pl, Stravix |
| Integra Lifesciences Corporation | $70.15 | 2019-2022 | |
| Horizon Therapeutics Plc | $55.82 | 2020-2023 | Krystexxa |
| Cashflow Solutions, LLC | $47.73 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Convatec INC. | $26.68 | 2023 | |
| Aroa Biosurgery Incorporated | $26.51 | 2020 | |
| Abbvie INC. | $23.17 | 2023 | Dalvance |
| Triad Life Sciences INC. | $16.40 | 2022 | |
| Kci USA, INC. | $14.64 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.38 | 2023 | Nuzyra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $13.62 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.